

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 8.49445813 |
| 2 | omega-hydroxylase P450 pathway (GO:0097267) | 8.19604001 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 7.73672467 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.73672467 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 7.41457782 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.41457782 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.96353227 |
| 8 | drug metabolic process (GO:0017144) | 6.46733137 |
| 9 | oxidative demethylation (GO:0070989) | 6.30899651 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.23798700 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.23798700 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.23798700 |
| 13 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.21873227 |
| 14 | urea metabolic process (GO:0019627) | 6.16481107 |
| 15 | urea cycle (GO:0000050) | 6.16481107 |
| 16 | kynurenine metabolic process (GO:0070189) | 6.09502990 |
| 17 | bile acid biosynthetic process (GO:0006699) | 5.98009812 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.87648541 |
| 19 | glyoxylate metabolic process (GO:0046487) | 5.86217791 |
| 20 | serine family amino acid catabolic process (GO:0009071) | 5.82450431 |
| 21 | cysteine metabolic process (GO:0006534) | 5.77880479 |
| 22 | response to mercury ion (GO:0046689) | 5.73134842 |
| 23 | nitrogen cycle metabolic process (GO:0071941) | 5.68704517 |
| 24 | sulfur amino acid catabolic process (GO:0000098) | 5.66514101 |
| 25 | phenylpropanoid metabolic process (GO:0009698) | 5.63795490 |
| 26 | negative regulation of fibrinolysis (GO:0051918) | 5.49714915 |
| 27 | alpha-linolenic acid metabolic process (GO:0036109) | 5.42774742 |
| 28 | high-density lipoprotein particle remodeling (GO:0034375) | 5.41029329 |
| 29 | homocysteine metabolic process (GO:0050667) | 5.37823117 |
| 30 | ethanol metabolic process (GO:0006067) | 5.35207689 |
| 31 | regulation of fibrinolysis (GO:0051917) | 5.25634470 |
| 32 | regulation of protein activation cascade (GO:2000257) | 5.23674176 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 5.22681383 |
| 34 | complement activation, alternative pathway (GO:0006957) | 5.14887618 |
| 35 | protein carboxylation (GO:0018214) | 5.14255254 |
| 36 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.14255254 |
| 37 | glycine metabolic process (GO:0006544) | 5.13793031 |
| 38 | regulation of plasminogen activation (GO:0010755) | 5.10340668 |
| 39 | bile acid metabolic process (GO:0008206) | 5.08895018 |
| 40 | tyrosine metabolic process (GO:0006570) | 5.01042142 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.95835452 |
| 42 | alpha-amino acid catabolic process (GO:1901606) | 4.90418589 |
| 43 | regulation of complement activation (GO:0030449) | 4.89053895 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 4.85845014 |
| 45 | regulation of triglyceride catabolic process (GO:0010896) | 4.83615918 |
| 46 | negative regulation of hemostasis (GO:1900047) | 4.81231871 |
| 47 | negative regulation of blood coagulation (GO:0030195) | 4.81231871 |
| 48 | serine family amino acid metabolic process (GO:0009069) | 4.76187169 |
| 49 | alkaloid metabolic process (GO:0009820) | 4.73862229 |
| 50 | * amino-acid betaine metabolic process (GO:0006577) | 4.70830398 |
| 51 | reverse cholesterol transport (GO:0043691) | 4.70425898 |
| 52 | lysine metabolic process (GO:0006553) | 4.69612300 |
| 53 | lysine catabolic process (GO:0006554) | 4.69612300 |
| 54 | protein-lipid complex remodeling (GO:0034368) | 4.69602930 |
| 55 | macromolecular complex remodeling (GO:0034367) | 4.69602930 |
| 56 | plasma lipoprotein particle remodeling (GO:0034369) | 4.69602930 |
| 57 | serine family amino acid biosynthetic process (GO:0009070) | 4.68118292 |
| 58 | cellular amino acid catabolic process (GO:0009063) | 4.52708112 |
| 59 | acylglycerol homeostasis (GO:0055090) | 4.49810096 |
| 60 | triglyceride homeostasis (GO:0070328) | 4.49810096 |
| 61 | * S-adenosylmethionine metabolic process (GO:0046500) | 4.49580025 |
| 62 | imidazole-containing compound metabolic process (GO:0052803) | 4.49449640 |
| 63 | phospholipid efflux (GO:0033700) | 4.46688695 |
| 64 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.46119659 |
| 65 | negative regulation of cholesterol transport (GO:0032375) | 4.44701160 |
| 66 | negative regulation of sterol transport (GO:0032372) | 4.44701160 |
| 67 | indolalkylamine metabolic process (GO:0006586) | 4.40824267 |
| 68 | cellular ketone body metabolic process (GO:0046950) | 4.38104153 |
| 69 | negative regulation of coagulation (GO:0050819) | 4.37274060 |
| 70 | amine catabolic process (GO:0009310) | 4.35612305 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 4.35612305 |
| 72 | bile acid and bile salt transport (GO:0015721) | 4.32539992 |
| 73 | arginine metabolic process (GO:0006525) | 4.30869903 |
| 74 | negative regulation of wound healing (GO:0061045) | 4.29711002 |
| 75 | glutamate metabolic process (GO:0006536) | 4.29216760 |
| 76 | plasma lipoprotein particle clearance (GO:0034381) | 4.27215591 |
| 77 | coenzyme catabolic process (GO:0009109) | 4.26963076 |
| 78 | flavonoid metabolic process (GO:0009812) | 4.19039332 |
| 79 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.10072027 |
| 80 | cholesterol efflux (GO:0033344) | 4.09890043 |
| 81 | cellular modified amino acid catabolic process (GO:0042219) | 4.07024233 |
| 82 | cellular glucuronidation (GO:0052695) | 4.05223434 |
| 83 | benzene-containing compound metabolic process (GO:0042537) | 4.04822232 |
| 84 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00239894 |
| 85 | acute-phase response (GO:0006953) | 3.97447736 |
| 86 | low-density lipoprotein particle remodeling (GO:0034374) | 3.97192388 |
| 87 | intestinal cholesterol absorption (GO:0030299) | 3.96922537 |
| 88 | aldehyde catabolic process (GO:0046185) | 3.96062152 |
| 89 | positive regulation of hemostasis (GO:1900048) | 3.94749490 |
| 90 | positive regulation of blood coagulation (GO:0030194) | 3.94749490 |
| 91 | regulation of humoral immune response (GO:0002920) | 3.93876619 |
| 92 | carboxylic acid catabolic process (GO:0046395) | 3.91838279 |
| 93 | organic acid catabolic process (GO:0016054) | 3.91838279 |
| 94 | plasma lipoprotein particle assembly (GO:0034377) | 3.91651926 |
| 95 | negative regulation of protein activation cascade (GO:2000258) | 3.89428866 |
| 96 | ethanol oxidation (GO:0006069) | 3.88421769 |
| 97 | fibrinolysis (GO:0042730) | 3.85849075 |
| 98 | sodium-independent organic anion transport (GO:0043252) | 3.84590930 |
| 99 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.82007922 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.82007922 |
| 101 | blood coagulation, intrinsic pathway (GO:0007597) | 3.81523801 |
| 102 | ketone body metabolic process (GO:1902224) | 3.78540021 |
| 103 | xenobiotic metabolic process (GO:0006805) | 3.77983376 |
| 104 | regulation of bile acid biosynthetic process (GO:0070857) | 3.74032382 |
| 105 | L-serine metabolic process (GO:0006563) | 3.72745927 |
| 106 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.72120923 |
| 107 | acetyl-CoA metabolic process (GO:0006084) | 3.69737429 |
| 108 | cholesterol homeostasis (GO:0042632) | 3.69637286 |
| 109 | hormone catabolic process (GO:0042447) | 3.68538757 |
| 110 | polyketide metabolic process (GO:0030638) | 3.68422669 |
| 111 | doxorubicin metabolic process (GO:0044598) | 3.68422669 |
| 112 | daunorubicin metabolic process (GO:0044597) | 3.68422669 |
| 113 | heme transport (GO:0015886) | 3.67930339 |
| 114 | phospholipid homeostasis (GO:0055091) | 3.67771349 |
| 115 | drug catabolic process (GO:0042737) | 3.67070653 |
| 116 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.64905101 |
| 117 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.64905101 |
| 118 | positive regulation of lipid catabolic process (GO:0050996) | 3.63874586 |
| 119 | cofactor catabolic process (GO:0051187) | 3.63721677 |
| 120 | positive regulation of coagulation (GO:0050820) | 3.63639928 |
| 121 | drug transmembrane transport (GO:0006855) | 3.63292656 |
| 122 | sterol homeostasis (GO:0055092) | 3.63069341 |
| 123 | negative regulation of lipase activity (GO:0060192) | 3.62675370 |
| 124 | complement activation, classical pathway (GO:0006958) | 3.62278985 |
| 125 | regulation of cholesterol homeostasis (GO:2000188) | 3.60445988 |
| 126 | steroid catabolic process (GO:0006706) | 3.60270083 |
| 127 | NAD biosynthetic process (GO:0009435) | 3.59596866 |
| 128 | complement activation (GO:0006956) | 3.58842432 |
| 129 | uronic acid metabolic process (GO:0006063) | 3.56263416 |
| 130 | glucuronate metabolic process (GO:0019585) | 3.56263416 |
| 131 | primary alcohol catabolic process (GO:0034310) | 3.56080094 |
| 132 | protein activation cascade (GO:0072376) | 3.55994807 |
| 133 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.55658794 |
| 134 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.55658794 |
| 135 | cytolysis (GO:0019835) | 3.55169107 |
| 136 | 2-oxoglutarate metabolic process (GO:0006103) | 3.55043286 |
| 137 | exogenous drug catabolic process (GO:0042738) | 10.1700885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.32500525 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.19165286 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.94321368 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.31705500 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.39208670 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.33812125 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.83267364 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.24862139 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.86274627 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.17769667 |
| 11 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06293090 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.02192046 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.0114141 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.90988424 |
| 15 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.70447838 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.53279172 |
| 17 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52576646 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.45507130 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.44132796 |
| 20 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.40952882 |
| 21 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.40779985 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.31514644 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30901615 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.27401460 |
| 25 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20378851 |
| 26 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.10277884 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04464846 |
| 28 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.03555224 |
| 29 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.02615741 |
| 30 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.02342762 |
| 31 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00848358 |
| 32 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.00582925 |
| 33 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.00537887 |
| 34 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00426053 |
| 35 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.99827644 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99113598 |
| 37 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.97753041 |
| 38 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.97045088 |
| 39 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.96055987 |
| 40 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95071197 |
| 41 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.91709196 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.90959066 |
| 43 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90438239 |
| 44 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89759682 |
| 45 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.89226628 |
| 46 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.88686559 |
| 47 | NFYA_21822215_ChIP-Seq_K562_Human | 0.87415288 |
| 48 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86581588 |
| 49 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.86548488 |
| 50 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84342332 |
| 51 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.83844109 |
| 52 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.83555449 |
| 53 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.80285089 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.79418444 |
| 55 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78169135 |
| 56 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.77979933 |
| 57 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.77558864 |
| 58 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.76103323 |
| 59 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.75308502 |
| 60 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.75252823 |
| 61 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.74457813 |
| 62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.74397519 |
| 63 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.73682490 |
| 64 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.73071313 |
| 65 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72124206 |
| 66 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.72084894 |
| 67 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.72033944 |
| 68 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.71889815 |
| 69 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.71838320 |
| 70 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.71558249 |
| 71 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.71249567 |
| 72 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.70205539 |
| 73 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.69869386 |
| 74 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.68627573 |
| 75 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.68204529 |
| 76 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.68131663 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.67236003 |
| 78 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.66802678 |
| 79 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64430962 |
| 80 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.64350126 |
| 81 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.64348396 |
| 82 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.64348396 |
| 83 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.64285401 |
| 84 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.64189309 |
| 85 | NFYB_21822215_ChIP-Seq_K562_Human | 0.64165704 |
| 86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.63530558 |
| 87 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.63321446 |
| 88 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.63003300 |
| 89 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.62966484 |
| 90 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.62545291 |
| 91 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.61617741 |
| 92 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.61569651 |
| 93 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.61341814 |
| 94 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.61274780 |
| 95 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.60979130 |
| 96 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.60663631 |
| 97 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.60591504 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.59830097 |
| 99 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.59763290 |
| 100 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.58581969 |
| 101 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.58442579 |
| 102 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.58302962 |
| 103 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.56895523 |
| 104 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.56839780 |
| 105 | * FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.56821986 |
| 106 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.56778167 |
| 107 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55614567 |
| 108 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.54049617 |
| 109 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.53216132 |
| 110 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.51509617 |
| 111 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.49405869 |
| 112 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.49287384 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.49133280 |
| 114 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.48957344 |
| 115 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.48086030 |
| 116 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.48079676 |
| 117 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.47879377 |
| 118 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.47804751 |
| 119 | AR_20517297_ChIP-Seq_VCAP_Human | 0.47730696 |
| 120 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.47006596 |
| 121 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.46196563 |
| 122 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.46048671 |
| 123 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.44002285 |
| 124 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.43986560 |
| 125 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.43859268 |
| 126 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.43824161 |
| 127 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.43557243 |
| 128 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.43092363 |
| 129 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.42531773 |
| 130 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.42382324 |
| 131 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.41909751 |
| 132 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.41861469 |
| 133 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.41576040 |
| 134 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.41527788 |
| 135 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.41414107 |
| 136 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41385950 |
| 137 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.41120130 |
| 138 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.41082381 |
| 139 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 0.40868591 |
| 140 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.40047507 |
| 141 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.39671096 |
| 142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39229282 |
| 143 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.39111701 |
| 144 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.38622044 |
| 145 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.38367689 |
| 146 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.38001988 |
| 147 | CBP_21632823_ChIP-Seq_H3396_Human | 0.37758195 |
| 148 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.36569123 |
| 149 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.36488029 |
| 150 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.36164315 |
| 151 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36058724 |
| 152 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.35676091 |
| 153 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.35071563 |
| 154 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 0.34108477 |
| 155 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34096791 |
| 156 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33938819 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.00967196 |
| 2 | MP0005360_urolithiasis | 7.42631736 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.44418451 |
| 4 | MP0005365_abnormal_bile_salt | 6.27265355 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.92875101 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.46865558 |
| 7 | MP0003252_abnormal_bile_duct | 3.81257975 |
| 8 | MP0009840_abnormal_foam_cell | 3.73726184 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.58208612 |
| 10 | MP0005332_abnormal_amino_acid | 3.05631823 |
| 11 | MP0005083_abnormal_biliary_tract | 2.88447357 |
| 12 | MP0003195_calcinosis | 2.85162190 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.56277090 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.34032428 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.33891903 |
| 16 | MP0000609_abnormal_liver_physiology | 2.21876555 |
| 17 | MP0002118_abnormal_lipid_homeostasis | 2.09388636 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.02889788 |
| 19 | MP0005451_abnormal_body_composition | 1.90683846 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.90401554 |
| 21 | MP0003868_abnormal_feces_composition | 1.90263894 |
| 22 | MP0001764_abnormal_homeostasis | 1.88794212 |
| 23 | MP0004043_abnormal_pH_regulation | 1.86029522 |
| 24 | MP0009697_abnormal_copulation | 1.62629172 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.52591719 |
| 26 | MP0003186_abnormal_redox_activity | 1.43041194 |
| 27 | MP0003011_delayed_dark_adaptation | 1.33146055 |
| 28 | MP0009643_abnormal_urine_homeostasis | 1.29666194 |
| 29 | MP0003656_abnormal_erythrocyte_physiolo | 1.29513725 |
| 30 | MP0000598_abnormal_liver_morphology | 1.23151529 |
| 31 | MP0000604_amyloidosis | 1.11237157 |
| 32 | MP0003705_abnormal_hypodermis_morpholog | 1.06911408 |
| 33 | MP0003718_maternal_effect | 1.06322175 |
| 34 | MP0005647_abnormal_sex_gland | 1.04036153 |
| 35 | MP0005670_abnormal_white_adipose | 1.00621212 |
| 36 | MP0009764_decreased_sensitivity_to | 0.98079421 |
| 37 | MP0001661_extended_life_span | 0.97977641 |
| 38 | MP0009763_increased_sensitivity_to | 0.96950467 |
| 39 | MP0005636_abnormal_mineral_homeostasis | 0.93281977 |
| 40 | MP0006036_abnormal_mitochondrial_physio | 0.91757923 |
| 41 | MP0002254_reproductive_system_inflammat | 0.91432996 |
| 42 | MP0005408_hypopigmentation | 0.89877640 |
| 43 | MP0008469_abnormal_protein_level | 0.88483673 |
| 44 | MP0009642_abnormal_blood_homeostasis | 0.86907495 |
| 45 | MP0002876_abnormal_thyroid_physiology | 0.84430615 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.83140139 |
| 47 | MP0003879_abnormal_hair_cell | 0.80008567 |
| 48 | MP0010368_abnormal_lymphatic_system | 0.77812364 |
| 49 | MP0003329_amyloid_beta_deposits | 0.77108555 |
| 50 | MP0001756_abnormal_urination | 0.77040307 |
| 51 | MP0006035_abnormal_mitochondrial_morpho | 0.76107776 |
| 52 | MP0009765_abnormal_xenobiotic_induced | 0.74576107 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 0.73270685 |
| 54 | MP0005395_other_phenotype | 0.72910409 |
| 55 | MP0009053_abnormal_anal_canal | 0.72674667 |
| 56 | MP0002078_abnormal_glucose_homeostasis | 0.71812420 |
| 57 | MP0005266_abnormal_metabolism | 0.66950292 |
| 58 | MP0005220_abnormal_exocrine_pancreas | 0.66465299 |
| 59 | MP0002971_abnormal_brown_adipose | 0.65876644 |
| 60 | MP0005334_abnormal_fat_pad | 0.65100843 |
| 61 | MP0002282_abnormal_trachea_morphology | 0.63813422 |
| 62 | MP0005187_abnormal_penis_morphology | 0.63788331 |
| 63 | MP0001915_intracranial_hemorrhage | 0.63731375 |
| 64 | MP0003690_abnormal_glial_cell | 0.60892540 |
| 65 | MP0005535_abnormal_body_temperature | 0.60524245 |
| 66 | MP0004130_abnormal_muscle_cell | 0.58835279 |
| 67 | MP0000639_abnormal_adrenal_gland | 0.51960083 |
| 68 | MP0008260_abnormal_autophagy | 0.51498252 |
| 69 | MP0004381_abnormal_hair_follicle | 0.50858456 |
| 70 | MP0009672_abnormal_birth_weight | 0.49932661 |
| 71 | MP0002136_abnormal_kidney_physiology | 0.47946685 |
| 72 | MP0005448_abnormal_energy_balance | 0.46149982 |
| 73 | MP0008873_increased_physiological_sensi | 0.46099538 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.44074575 |
| 75 | MP0005464_abnormal_platelet_physiology | 0.44036898 |
| 76 | MP0002249_abnormal_larynx_morphology | 0.42367078 |
| 77 | MP0005058_abnormal_lysosome_morphology | 0.40966089 |
| 78 | MP0001765_abnormal_ion_homeostasis | 0.39291467 |
| 79 | MP0003953_abnormal_hormone_level | 0.38773242 |
| 80 | MP0004782_abnormal_surfactant_physiolog | 0.37938555 |
| 81 | MP0005666_abnormal_adipose_tissue | 0.37918773 |
| 82 | MP0008961_abnormal_basal_metabolism | 0.37041207 |
| 83 | MP0001853_heart_inflammation | 0.36560244 |
| 84 | MP0003959_abnormal_lean_body | 0.35909652 |
| 85 | MP0002822_catalepsy | 0.35456197 |
| 86 | MP0000230_abnormal_systemic_arterial | 0.34300146 |
| 87 | MP0002796_impaired_skin_barrier | 0.34228564 |
| 88 | MP0008874_decreased_physiological_sensi | 0.32542789 |
| 89 | MP0009785_altered_susceptibility_to | 0.32031025 |
| 90 | MP0009115_abnormal_fat_cell | 0.31382858 |
| 91 | MP0002168_other_aberrant_phenotype | 0.31320602 |
| 92 | MP0005248_abnormal_Harderian_gland | 0.30867144 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.30556648 |
| 94 | MP0005023_abnormal_wound_healing | 0.30297094 |
| 95 | MP0002970_abnormal_white_adipose | 0.29563722 |
| 96 | MP0001243_abnormal_dermal_layer | 0.29339758 |
| 97 | MP0000579_abnormal_nail_morphology | 0.29267516 |
| 98 | MP0008872_abnormal_physiological_respon | 0.29042801 |
| 99 | MP0002269_muscular_atrophy | 0.28983811 |
| 100 | MP0001542_abnormal_bone_strength | 0.28760362 |
| 101 | MP0003724_increased_susceptibility_to | 0.28147249 |
| 102 | MP0002928_abnormal_bile_duct | 0.27965116 |
| 103 | MP0001881_abnormal_mammary_gland | 0.27881864 |
| 104 | MP0003436_decreased_susceptibility_to | 0.27495022 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.27429572 |
| 106 | MP0002132_abnormal_respiratory_system | 0.27352995 |
| 107 | MP0000467_abnormal_esophagus_morphology | 0.27197083 |
| 108 | MP0004883_abnormal_blood_vessel | 0.27022406 |
| 109 | MP0003699_abnormal_female_reproductive | 0.26746859 |
| 110 | MP0004142_abnormal_muscle_tone | 0.26731434 |
| 111 | MP0005166_decreased_susceptibility_to | 0.26512235 |
| 112 | MP0000249_abnormal_blood_vessel | 0.25858917 |
| 113 | MP0002135_abnormal_kidney_morphology | 0.24987799 |
| 114 | MP0003878_abnormal_ear_physiology | 0.24966316 |
| 115 | MP0005377_hearing/vestibular/ear_phenot | 0.24966316 |
| 116 | MP0001845_abnormal_inflammatory_respons | 0.24950795 |
| 117 | MP0003075_altered_response_to | 0.24192460 |
| 118 | MP0005164_abnormal_response_to | 0.23067851 |
| 119 | MP0002069_abnormal_eating/drinking_beha | 0.22536496 |
| 120 | MP0001944_abnormal_pancreas_morphology | 0.21705162 |
| 121 | MP0000566_synostosis | 0.21369438 |
| 122 | MP0001851_eye_inflammation | 0.20417455 |
| 123 | MP0005197_abnormal_uvea_morphology | 0.18100084 |
| 124 | MP0002332_abnormal_exercise_endurance | 0.15912666 |
| 125 | MP0003300_gastrointestinal_ulcer | 0.15830386 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.45249104 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.06909794 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 7.05923110 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.98112071 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.55323481 |
| 6 | Xanthomatosis (HP:0000991) | 6.34407390 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.28837340 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.68690305 |
| 9 | Hyperglycinemia (HP:0002154) | 5.11966503 |
| 10 | Complement deficiency (HP:0004431) | 5.02068299 |
| 11 | Hypolipoproteinemia (HP:0010981) | 4.89888380 |
| 12 | Hyperammonemia (HP:0001987) | 4.84204900 |
| 13 | Abnormality of methionine metabolism (HP:0010901) | 4.77344808 |
| 14 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.62199236 |
| 15 | Hyperglycinuria (HP:0003108) | 4.55283536 |
| 16 | Epidermoid cyst (HP:0200040) | 4.49300274 |
| 17 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.49217025 |
| 18 | Joint hemorrhage (HP:0005261) | 4.48167810 |
| 19 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.46164566 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 4.41490753 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.41490753 |
| 22 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.29927983 |
| 23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.29475092 |
| 24 | Abnormality of the common coagulation pathway (HP:0010990) | 4.22951117 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.22829532 |
| 26 | Ketosis (HP:0001946) | 4.08118439 |
| 27 | Fat malabsorption (HP:0002630) | 4.02280923 |
| 28 | Increased circulating renin level (HP:0000848) | 3.86096706 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.81812918 |
| 30 | Abnormality of serum amino acid levels (HP:0003112) | 3.69826283 |
| 31 | Abnormality of complement system (HP:0005339) | 3.63804930 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.55130023 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.52285459 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.49621283 |
| 35 | Conjugated hyperbilirubinemia (HP:0002908) | 3.47131141 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.46005487 |
| 37 | Nephritis (HP:0000123) | 3.38990105 |
| 38 | Metabolic alkalosis (HP:0200114) | 3.28248048 |
| 39 | Abnormality of nucleobase metabolism (HP:0010932) | 3.25766523 |
| 40 | Hyperbilirubinemia (HP:0002904) | 3.17817054 |
| 41 | Hypokalemic alkalosis (HP:0001949) | 3.17427157 |
| 42 | Delayed CNS myelination (HP:0002188) | 3.10152486 |
| 43 | Hyperphosphaturia (HP:0003109) | 3.03080153 |
| 44 | Steatorrhea (HP:0002570) | 3.00406935 |
| 45 | Osteomalacia (HP:0002749) | 2.97608495 |
| 46 | Lethargy (HP:0001254) | 2.94165543 |
| 47 | Spontaneous abortion (HP:0005268) | 2.93582337 |
| 48 | Hyperactive renin-angiotensin system (HP:0000841) | 2.90555187 |
| 49 | Gout (HP:0001997) | 2.88212000 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.82528766 |
| 51 | Myocardial infarction (HP:0001658) | 2.82140254 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.80561189 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 2.80561189 |
| 54 | Skin nodule (HP:0200036) | 2.79647881 |
| 55 | Metabolic acidosis (HP:0001942) | 2.77882471 |
| 56 | Ketoacidosis (HP:0001993) | 2.73888230 |
| 57 | Abnormality of purine metabolism (HP:0004352) | 2.73685793 |
| 58 | Hypochromic microcytic anemia (HP:0004840) | 2.70768856 |
| 59 | Cerebral edema (HP:0002181) | 2.63571822 |
| 60 | Irritability (HP:0000737) | 2.61549308 |
| 61 | Spastic diplegia (HP:0001264) | 2.54800653 |
| 62 | Hypomagnesemia (HP:0002917) | 2.53831978 |
| 63 | Acanthocytosis (HP:0001927) | 2.48542785 |
| 64 | Fair hair (HP:0002286) | 2.47826441 |
| 65 | Systemic lupus erythematosus (HP:0002725) | 2.46082010 |
| 66 | Abnormal urine phosphate concentration (HP:0012599) | 2.42126074 |
| 67 | Vascular calcification (HP:0004934) | 2.41504380 |
| 68 | Neonatal onset (HP:0003623) | 2.35067550 |
| 69 | Malnutrition (HP:0004395) | 2.33790833 |
| 70 | Abnormal urine output (HP:0012590) | 2.32217887 |
| 71 | Glomerulonephritis (HP:0000099) | 2.29625885 |
| 72 | Brushfield spots (HP:0001088) | 2.24355169 |
| 73 | Polyuria (HP:0000103) | 2.22294978 |
| 74 | Mitral stenosis (HP:0001718) | 2.21360047 |
| 75 | Hypoglycemic seizures (HP:0002173) | 2.20635683 |
| 76 | Abnormality of chloride homeostasis (HP:0011422) | 2.18098435 |
| 77 | Abnormal gallbladder morphology (HP:0012437) | 2.16627340 |
| 78 | Reduced antithrombin III activity (HP:0001976) | 2.15533011 |
| 79 | Neonatal hypoglycemia (HP:0001998) | 2.14550222 |
| 80 | Cardiovascular calcification (HP:0011915) | 2.12331912 |
| 81 | Cholelithiasis (HP:0001081) | 2.11700008 |
| 82 | Purpura (HP:0000979) | 2.11588842 |
| 83 | Hypokalemia (HP:0002900) | 2.11381323 |
| 84 | Vomiting (HP:0002013) | 2.11106545 |
| 85 | Pancreatitis (HP:0001733) | 2.09730107 |
| 86 | Pulmonary embolism (HP:0002204) | 2.09087092 |
| 87 | Generalized aminoaciduria (HP:0002909) | 2.08123480 |
| 88 | Hyperaldosteronism (HP:0000859) | 2.07863304 |
| 89 | Abnormal cartilage morphology (HP:0002763) | 2.07268252 |
| 90 | Hypophosphatemic rickets (HP:0004912) | 2.06017462 |
| 91 | Esophageal varix (HP:0002040) | 2.05519413 |
| 92 | Sensorimotor neuropathy (HP:0007141) | 2.05135166 |
| 93 | Abnormality of magnesium homeostasis (HP:0004921) | 2.04600275 |
| 94 | Elevated alkaline phosphatase (HP:0003155) | 2.04555917 |
| 95 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.03800049 |
| 96 | Arthropathy (HP:0003040) | 2.03459301 |
| 97 | Proximal tubulopathy (HP:0000114) | 2.02476776 |
| 98 | Abnormality of renal excretion (HP:0011036) | 2.02463467 |
| 99 | Amyloidosis (HP:0011034) | 2.02438070 |
| 100 | Gingival bleeding (HP:0000225) | 2.01060762 |
| 101 | Renal salt wasting (HP:0000127) | 1.98833870 |
| 102 | Alkalosis (HP:0001948) | 1.98545407 |
| 103 | Opisthotonus (HP:0002179) | 1.98519488 |
| 104 | Impaired platelet aggregation (HP:0003540) | 1.97970179 |
| 105 | Abnormal platelet function (HP:0011869) | 1.97970179 |
| 106 | Hyperglycemia (HP:0003074) | 1.97838125 |
| 107 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.96134416 |
| 108 | Increased purine levels (HP:0004368) | 1.94585888 |
| 109 | Hyperuricemia (HP:0002149) | 1.94585888 |
| 110 | Nausea (HP:0002018) | 1.94495879 |
| 111 | Cholecystitis (HP:0001082) | 1.92547834 |
| 112 | Abnormal gallbladder physiology (HP:0012438) | 1.92547834 |
| 113 | Thrombophlebitis (HP:0004418) | 1.92234218 |
| 114 | Enlarged kidneys (HP:0000105) | 1.90412555 |
| 115 | Poikilocytosis (HP:0004447) | 1.90092335 |
| 116 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.89591620 |
| 117 | Menorrhagia (HP:0000132) | 1.89496080 |
| 118 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.89468312 |
| 119 | Renal cortical cysts (HP:0000803) | 1.89004019 |
| 120 | Abnormality of iron homeostasis (HP:0011031) | 1.86348627 |
| 121 | Late onset (HP:0003584) | 1.85141256 |
| 122 | Facial shape deformation (HP:0011334) | 1.81735921 |
| 123 | Potter facies (HP:0002009) | 1.81735921 |
| 124 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.81514906 |
| 125 | Abnormality of proline metabolism (HP:0010907) | 1.80797445 |
| 126 | Hydroxyprolinuria (HP:0003080) | 1.80797445 |
| 127 | Bifid scrotum (HP:0000048) | 1.80125055 |
| 128 | Spastic paraparesis (HP:0002313) | 1.79518121 |
| 129 | Hypophosphatemia (HP:0002148) | 1.78879748 |
| 130 | Bile duct proliferation (HP:0001408) | 1.78334975 |
| 131 | Abnormal biliary tract physiology (HP:0012439) | 1.78334975 |
| 132 | Elevated hepatic transaminases (HP:0002910) | 1.77088373 |
| 133 | Abnormality of vitamin metabolism (HP:0100508) | 1.76146309 |
| 134 | Hemorrhage of the eye (HP:0011885) | 1.75798129 |
| 135 | Rickets (HP:0002748) | 1.75073408 |
| 136 | Glycosuria (HP:0003076) | 1.74961794 |
| 137 | Abnormality of urine glucose concentration (HP:0011016) | 1.74961794 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.61656515 |
| 2 | OXSR1 | 6.24971718 |
| 3 | FGFR4 | 4.30309318 |
| 4 | SIK1 | 3.91492517 |
| 5 | ERN1 | 3.30582836 |
| 6 | ERBB4 | 2.60205694 |
| 7 | INSRR | 2.47409749 |
| 8 | TAOK3 | 2.43289481 |
| 9 | IRAK3 | 2.41415380 |
| 10 | WNK4 | 2.29059361 |
| 11 | AKT3 | 2.16737532 |
| 12 | MST1R | 2.14061285 |
| 13 | WNK3 | 10.5087602 |
| 14 | SGK494 | 1.98355831 |
| 15 | SGK223 | 1.98355831 |
| 16 | MAP2K4 | 1.93641544 |
| 17 | RIPK1 | 1.89439188 |
| 18 | ABL2 | 1.85249529 |
| 19 | EPHA2 | 1.83884722 |
| 20 | MAPK11 | 1.78717208 |
| 21 | PIK3CA | 1.77579387 |
| 22 | STK16 | 1.72890069 |
| 23 | PIK3CG | 1.67871798 |
| 24 | PINK1 | 1.62233145 |
| 25 | LATS1 | 1.49402923 |
| 26 | TYK2 | 1.46107917 |
| 27 | FLT3 | 1.45661542 |
| 28 | PKN2 | 1.44751646 |
| 29 | KDR | 1.44555639 |
| 30 | BUB1 | 1.43982408 |
| 31 | STK39 | 1.43689731 |
| 32 | BCR | 1.36559602 |
| 33 | NEK9 | 1.34061781 |
| 34 | NTRK3 | 1.33433296 |
| 35 | WEE1 | 1.33178179 |
| 36 | TRIB3 | 1.27172564 |
| 37 | STK38L | 1.24062012 |
| 38 | FRK | 1.18655488 |
| 39 | PDK3 | 1.14267913 |
| 40 | PDK4 | 1.14267913 |
| 41 | FGFR2 | 1.10194738 |
| 42 | DAPK2 | 1.07047498 |
| 43 | EIF2AK1 | 1.06772630 |
| 44 | TSSK6 | 1.00713036 |
| 45 | MAPK4 | 0.98667772 |
| 46 | PTK6 | 0.97670959 |
| 47 | JAK2 | 0.96923400 |
| 48 | ZAK | 0.96196043 |
| 49 | PLK4 | 0.93264842 |
| 50 | PRKAA2 | 0.92958954 |
| 51 | NEK1 | 0.92133579 |
| 52 | NLK | 0.91652048 |
| 53 | ERBB2 | 0.90950243 |
| 54 | PRKCZ | 0.89439622 |
| 55 | FGFR3 | 0.88654395 |
| 56 | MAP3K11 | 0.87172979 |
| 57 | MAP3K12 | 0.87046787 |
| 58 | MAP3K3 | 0.86936508 |
| 59 | CAMK2G | 0.84170437 |
| 60 | FER | 0.83972460 |
| 61 | GRK6 | 0.81732429 |
| 62 | IRAK2 | 0.79477422 |
| 63 | MYLK | 0.74450192 |
| 64 | MAP2K3 | 0.74045839 |
| 65 | PRKAA1 | 0.73949834 |
| 66 | PRKACA | 0.73537852 |
| 67 | TBK1 | 0.72534834 |
| 68 | CDK6 | 0.72446789 |
| 69 | CSNK1G1 | 0.71178345 |
| 70 | CDK4 | 0.70225176 |
| 71 | PRKACG | 0.70177032 |
| 72 | MET | 0.69773633 |
| 73 | MAPK12 | 0.68034659 |
| 74 | JAK1 | 0.66532186 |
| 75 | PRKG1 | 0.66191767 |
| 76 | SGK1 | 0.64842514 |
| 77 | MAP3K7 | 0.64610023 |
| 78 | PDK2 | 0.64513292 |
| 79 | PRKCG | 0.64165551 |
| 80 | TIE1 | 0.61460021 |
| 81 | TNK2 | 0.60888475 |
| 82 | EPHA4 | 0.60829813 |
| 83 | MAP4K2 | 0.60237939 |
| 84 | IRAK1 | 0.59995694 |
| 85 | TTK | 0.59914974 |
| 86 | LATS2 | 0.59839233 |
| 87 | MAP3K2 | 0.59183170 |
| 88 | MAP3K10 | 0.58753496 |
| 89 | MAPK7 | 0.58615477 |
| 90 | GSK3A | 0.56607970 |
| 91 | EPHA3 | 0.55457082 |
| 92 | CSNK1A1 | 0.54509350 |
| 93 | TESK2 | 0.52897184 |
| 94 | PNCK | 0.52783586 |
| 95 | CSNK1G3 | 0.52728130 |
| 96 | MAP2K6 | 0.51028133 |
| 97 | TAOK2 | 0.50566711 |
| 98 | CAMKK2 | 0.50211443 |
| 99 | PDPK1 | 0.50046115 |
| 100 | STK3 | 0.49197460 |
| 101 | GRK1 | 0.48187770 |
| 102 | PRKCB | 0.48159910 |
| 103 | ADRBK2 | 0.47790363 |
| 104 | PRKCA | 0.47182036 |
| 105 | MAP3K5 | 0.46401868 |
| 106 | SGK3 | 0.43147227 |
| 107 | DYRK1B | 0.43127134 |
| 108 | MTOR | 0.42910575 |
| 109 | MAPKAPK3 | 0.42776393 |
| 110 | EPHB1 | 0.42145116 |
| 111 | RPS6KA3 | 0.40864031 |
| 112 | CSNK1G2 | 0.40756341 |
| 113 | ACVR1B | 0.40692318 |
| 114 | MAP2K2 | 0.40588168 |
| 115 | MAPK15 | 0.40536351 |
| 116 | NUAK1 | 0.40529751 |
| 117 | RET | 0.40501858 |
| 118 | CSNK1D | 0.40472949 |
| 119 | BRSK2 | 0.40072329 |
| 120 | MAP2K1 | 0.37906973 |
| 121 | CSF1R | 0.37899355 |
| 122 | PBK | 0.35069248 |
| 123 | MAP3K14 | 0.34211131 |
| 124 | SRC | 0.34000311 |
| 125 | CSNK1E | 0.33912304 |
| 126 | CSNK1A1L | 0.33344716 |
| 127 | PRKCE | 0.31809072 |
| 128 | STK38 | 0.31577800 |
| 129 | NME2 | 0.29812612 |
| 130 | CSK | 0.29561881 |
| 131 | PTK2 | 0.29478032 |
| 132 | IGF1R | 0.27356786 |
| 133 | PDK1 | 0.27091971 |
| 134 | EIF2AK3 | 0.25791509 |
| 135 | BRAF | 0.24677039 |
| 136 | SGK2 | 0.24556665 |
| 137 | PAK3 | 0.24515892 |
| 138 | CASK | 0.23840159 |
| 139 | PRKACB | 0.23581021 |
| 140 | CHUK | 0.22154503 |
| 141 | MAP3K1 | 0.21145765 |
| 142 | PRPF4B | 0.21010088 |
| 143 | CSNK2A1 | 0.19307235 |
| 144 | PRKCD | 0.19148874 |
| 145 | TGFBR2 | 0.18849488 |
| 146 | MAP3K13 | 0.17161574 |
| 147 | CAMK4 | 0.13596057 |
| 148 | MAPK3 | 0.12617000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.45008186 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.74650731 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.53626237 |
| 4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.23390647 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.16196257 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.77264347 |
| 7 | * Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.75723774 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.58140780 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56759467 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.44230667 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.42636257 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.39059758 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.16239634 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.11467527 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.04689037 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.95507504 |
| 17 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.90661666 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89390045 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.88975778 |
| 20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.88123366 |
| 21 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.86605812 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.81080652 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.78314183 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78033891 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.77705501 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.75635963 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72595072 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.66845222 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.66541169 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.66527964 |
| 31 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.63095139 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.61476931 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.59633671 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.59281612 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.56842699 |
| 36 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.53009456 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50646171 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.49316574 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.43154184 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41073471 |
| 41 | Bile secretion_Homo sapiens_hsa04976 | 1.30719429 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.27830560 |
| 43 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.27117930 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27026398 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.24694021 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.14635253 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.13189101 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.07269363 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04895942 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.04759647 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01164414 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98043527 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97351084 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.94680907 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.90674825 |
| 56 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90243027 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.90040451 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89252285 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.85003675 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75116253 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71797907 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.71588868 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69207200 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67433183 |
| 65 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56412626 |
| 66 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.53359265 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.44648537 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.43997235 |
| 69 | Prion diseases_Homo sapiens_hsa05020 | 0.35543939 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35385646 |
| 71 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.32110410 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.32037704 |
| 73 | Galactose metabolism_Homo sapiens_hsa00052 | 0.28675355 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.26671096 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.22795768 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20331157 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.17475563 |
| 78 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16820371 |
| 79 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16674263 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.14281219 |
| 81 | Proteasome_Homo sapiens_hsa03050 | 0.05483610 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.02559794 |
| 83 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02029799 |
| 84 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.00279864 |
| 85 | Collecting duct acid secretion_Homo sapiens_hsa04966 | -0.2543001 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2490030 |
| 87 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2457560 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2298298 |
| 89 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.2293734 |
| 90 | Hepatitis C_Homo sapiens_hsa05160 | -0.2282950 |
| 91 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.2260413 |
| 92 | Circadian rhythm_Homo sapiens_hsa04710 | -0.2233450 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2188605 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2180921 |
| 95 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.2166716 |
| 96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2114636 |
| 97 | Purine metabolism_Homo sapiens_hsa00230 | -0.2102315 |
| 98 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.1847756 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1794810 |
| 100 | Amoebiasis_Homo sapiens_hsa05146 | -0.1792450 |
| 101 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1548536 |
| 102 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.1498350 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1465502 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1455336 |
| 105 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1388875 |
| 106 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1255514 |
| 107 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1213711 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1191316 |
| 109 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1178523 |
| 110 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0588443 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | -0.0490445 |
| 112 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0197477 |

